-R Edward Coleman Researcher Activity Profile

Research Author Detailed Information 

R Edward Coleman Publication Rate By Year

R Edward Coleman has published 2 paper(s) in 1976, 2 paper(s) in 1978, 3 paper(s) in 1984, 2 paper(s) in 1993, 1 paper(s) in 1995, 2 paper(s) in 1997, 3 paper(s) in 1998, 2 paper(s) in 1999, 1 paper(s) in 2000, 1 paper(s) in 2001, 1 paper(s) in 2005, 3 paper(s) in 2006, 27 paper(s) in 2007, 11 paper(s) in 2008, for a total of 61 research publications in total.

R Edward Re Coleman Author Information

LAST NAME: coleman

FIRST NAME: R Edward

INITIALS: re

AFFILIATION:

Papers

R Edward Coleman's Publication Record

1. Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease. Year Published: 2006
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. simon.bacon@concordia.ca
2. Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Year Published: 2006
Departments of Entomology and Immunology, US Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. russell.coleman@na.amedd.army.mil
3. Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT. Year Published: 2006
Department of Medicine, Division of Cardiology, Duke University Medical Center, Box 3808 DUMC, Durham, NC 27710, USA.
4. Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 2. Temporal and geographic distribution of sand flies. Year Published: 2007
520th Theater Army Medical Laboratory, United States Army, Tallil Air Base, Iraq. russell.coleman@us.army.mil
5. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. Year Published: 2007
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
6. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Year Published: 2007
Department of Surgery, Division of Neurosurgery, Duke university Medical Center, Durham, NC 27710, USA. john.sampson@duke.edu
7. Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid. Year Published: 2007
Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, United Kingdom. J.E.Brown@leeds.ac.uk
8. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Year Published: 2007
Milton S. Hershey Medical Center, Penn State Cancer Institute, 500 University Drive, Hershey, Pennsylvania 17033, USA. alipton@psu.edu
9. Left ventricular functional assessment in mice: feasibility of high spatial and temporal resolution ECG-gated blood pool SPECT. Year Published: 2007
Department of Radiology, Duke University School of Medicine, Durham, NC 27710, USA. chin0004@mc.duke.edu
10. The National Oncologic PET Registry (NOPR): design and analysis plan. Year Published: 2007
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0170, USA. hillner@vcu.edu
11. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. Year Published: 2007
Academic Unit of Clinical Oncology, Weston Park Hospital University of Sheffield, Sheffield, S10 2SJ, UK.
12. Regional brain activity correlates of nicotine dependence. Year Published: 2007
1Department of Psychiatry, Duke University Medical Center, Durham, NC, USA.
13. The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Year Published: 2007
Academic Unit of Clinical Oncology, D Floor, School of Medicine and Biomedical Sciences, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
14. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Year Published: 2007
Milton S. Hershey Medical Center, Penn State Cancer Institute, 500 University Drive, Hershey, Pennsylvania 17033, USA. alipton@psu.edu
15. Regional brain activity correlates of nicotine dependence. Year Published: 2007
Department of Psychiatry, Duke University Medical Center, Durham, NC 27705, USA. rose0003@mc.duke.edu
16. Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid. Year Published: 2007
Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, United Kingdom. J.E.Brown@leeds.ac.uk
17. The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Year Published: 2007
Academic Unit of Clinical Oncology, D Floor, School of Medicine and Biomedical Sciences, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
18. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. Year Published: 2007
Academic Unit of Clinical Oncology, Weston Park Hospital University of Sheffield, Sheffield S10 2SJ, UK. J.E.Brown@leeds.ac.uk
19. The National Oncologic PET Registry (NOPR): design and analysis plan. Year Published: 2007
Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0170, USA. hillner@vcu.edu
20. A quantitative comparison of attenuation-weighted backprojection with multiplicative and iterative postprocessing attenuation compensation in SPECT. Year Published: 2008
Dept. of Radiol., Syracuse Univ., NY.
21. Introduction. Year Published: 2007
22. Emerging strategies in bone health management for the adjuvant patient. Year Published: 2007
Cancer Research Centre, Head, Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk
23. Maximum likelihood reconstruction for pinhole SPECT with a displaced center-of-rotation. Year Published: 2008
Dept. of Radiol., Duke Univ. Med. Center, Durham, NC.
24. Bayesian reconstruction and use of anatomical a priori information for emission tomography. Year Published: 2008
Dept. of Radiol., Duke Univ. Med. Center, Durham, NC.
25. Clinical experience with alpha-Particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6. Year Published: 2007
Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA. zalut001@mc.duke.edu
26. Reconstruction of SPECT images using generalized matrix inverses. Year Published: 2008
Duke Univ., Durham, NC.
27. Solid geometry-based object model for Monte Carlo simulated emission and transmission tomographic imaging systems. Year Published: 2008
Dept. of Radiol., Duke Univ., Med. Center, Durham, NC.
28. The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Year Published: 2007
Academic Unit of Clinical Oncology, D Floor, School of Medicine and Biomedical Sciences, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
29. The benefits and costs of bisphosphonates. Year Published: 2008
University of Sheffield, Hospital, Sheffield, United Kingdom. R.E.Coleman@sheffield.ac.uk
30. Preserving skeletal wellness throughout the continuum of care in patients with cancer. Introduction. Year Published: 2007
31. Emerging strategies in bone health management for the adjuvant patient. Year Published: 2007
Cancer Research Centre, Head, Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk
32. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Year Published: 2001
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
33. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. Year Published: 1993
Department of Radiology, Duke University Medical Center, Durham, NC 27710.
34. Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS. Year Published: 1995
35. Regional brain activity correlates of nicotine dependence. Year Published: 2007
Department of Psychiatry, Duke University Medical Center, Durham, NC 27705, USA. rose0003@mc.duke.edu
36. Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV Measurements. Year Published: 2008
Department of Radiology, Nuclear Medicine Section, Duke University Medical Center, Durham, NC, 27710, USA, tbunyaviroch@hotmail.com.
37. Pediatric body applications of FDG PET. Year Published: 1999
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
38. Gangliogliomas: characterization by registered positron emission tomography-MR images. Year Published: 1999
Department of Radiology, Duke University Medical Center, Durham, NC 27710-3808, USA.
39. FDG PET of pleural effusions in patients with non-small cell lung cancer. Year Published: 2000
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
40. Computed tomography of the heart. Year Published: 1976
41. Correlation of renal images on bone scan and intravenous pyelogram. Year Published: 1976
42. Localization of 67Ga citrate in a mycotic aneurysm. Year Published: 1978
43. 131I-labeled fibrinogen in the diagnosis of deep vein thrombosis of the lower extremities. Year Published: 1978
44. An imaging approach to persistent neonatal jaundice. Year Published: 1984
45. Computed tomography in the evaluation of thyroid disease. Year Published: 1984
46. Ventilation-perfusion scanning and pulmonary angiography: correlation in clinical high-probability pulmonary embolism. Year Published: 1984
47. An interactive, computer-based atlas of neurologic positron emission tomographic studies for use in teaching. Year Published: 1993
Department of Radiology, Duke University Medical Center, Durham, NC 27713.
48. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. Year Published: 1997
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
49. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. Year Published: 1997
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
50. Evaluation of primary pulmonary carcinoid tumors using FDG PET. Year Published: 1998
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
51. Limbic encephalitis: comparison of FDG PET and MR imaging findings. Year Published: 1998
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
52. Diagnosis of pancreatic carcinoma: role of FDG PET. Year Published: 1998
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
53. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. Year Published: 2005
Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Box 3949, Durham, NC 27710, USA. wong0015@mc.duke.edu
54. Practical approach to diagnostic CT combined with PET. Year Published: 2007
Department of Radiology, Duke University Medical Center, Box 3949 Duke University Medical Center, Durham, NC 27710, USA. wong0015@mc.duke.edu
55. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. Year Published: 2007
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
56. The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development. Year Published: 2007
Foley Hoag, LLP, 155 Seaport Blvd., Boston, MA 02210-2600, USA. mlindsay@foleyhoag.com
57. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. Year Published: 2007
Academic Unit of Clinical Oncology, Weston Park Hospital University of Sheffield, Sheffield S10 2SJ, UK. J.E.Brown@leeds.ac.uk
58. Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements. Year Published: 2008
Department of Radiology, Nuclear Medicine Section, Duke University Medical Center, Durham, NC 27710, USA. tbunyaviroch@hotmail.com
59. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. Year Published: 2008
Department of Radiology, Indiana University School of Medicine, University Hospital, Indianapolis, Indiana 46202-5253, USA. jwfletch@iupui.edu
60. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Year Published: 2008
South Manchester University Hospital, Academic Surgery, Education and Research Center, Manchester, UK. Nigel.J.Bundred@manchester.ac.u
61. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma. Year Published: 2008
Department of Radiology, Duke University Medical Center, Erwin Rd, Durham, NC 27710, USA.